Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2
|
|
- Phoebe Sanders
- 5 years ago
- Views:
Transcription
1 Preoperative nomogram for individualized prediction of parametrial invasion in patients with FIGO stage IB cervical cancer treated with radical hysterectomy Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2 1 Gynecologic Cancer Center, Department of 2 Obstetrics and Gynecology, Department of 3 Pathology, and Department of 4 Radiology, Ajou University School of Medicine, Suwon, Korea
2 FIGO stage IB cervical cancer Piver type III radical hysterectomy (RH) Excellent local tumor control Long-term urologic complications (36%-47%) Sexual dysfunction Colorectal motility disorder Piver MS et al., 1974; Landoni F et al., 2001; Axelsen SM et al., 2006; Hazewinkel MH et al., 2010; Manchana T et al., 2010
3 Radical hysterectomy vs. radiation therapy FIGO stage IB-IIA, 343 patients randomized to either RH or radiation Survival: 83% (surgery) vs. 74% (radiation) Morbidity, esp., urologic complications 28% (RH) vs. 12% (radiation). P= NCCN guidelines for FIGO stage IB2 chemoradiation (category 1), RH (category 2B) Treatment facilities, physician preference, costs, performance status Landoni F et al., 1997
4 Cost effectiveness and utility RH is cost effective for treating FIGO stage IB2 (vs. chemoradiation) Cost utility analysis Clinical and cost outcomes including survival, quality of life, cost of treating each complication RH plus adjuvant therapy Less cost effective Minimize postoperative chemoradiation Rocconi RP et al., 2005; Jewell EL et al., 2007; Katanyoo K et al., 2014; Cohn DE, 2014
5 Parametrial spread High-risk pathologic factors Positive margins, lymph node metastasis, parametrial invasion (PMI) Parametrial spread FIGO stage IB1 (5% - 10%), IB2/IIA2 (36.4%) cervical cancer Randomly located in the lateral and medial parametria Difficult to predict PMI for less radical surgery Girardi F et al., 1989; Landoni F et al., 1995; Benedetti-Panici P et al., 2000; Wright JD et al., 2007; Frumovitz M et al., 2009; Chang SJ et al., 2012; Park JY et al., 2013; Lee JY et al., 2014; Kong TW et al., 2014; Kato T et al., 2015; Kong TW et al., 2016
6 Clinical tumor size & SCC-Ag level (AUC = 0.789) Chang SJ et al., 2012
7 Pre-menopause Post-menopause MRI tumor size, SCC-Ag, Cyfra 21-1, Menopause (AUC = in pre-menopause and in post-menopause) Kong TW et al., 2016
8 Table. Correlation between SCC Ag and tumor volume measured by MRI in invasive cervical carcinoma Tumor volume (ml) Number of patients SCC Ag (ng/ml) < ± ± ± ± ± 2.98 > ± γ 2 = 0.71, p = 0.01 Chung TY et al., 1996
9 Diameter-based ellipsoidal method Clinical tumor size MRI tumor size MRI tumor volume Hanato K et al., 1999; Mayr NA et al., 2002; Lee DW et al., 2010
10 Cervical stroma and tumor on T2-weighted MR images Tumor Intact cervical stromal ring Tumor Focal disruption of cervical stromal ring Radiological signs of PMI Disruption of cervical stromal ring High negative predictive value (94%-100%) Kim SH et al., 1990; Hricak H et al., 1998
11 Objectives To establish a preoperative nomogram predicting parametrial invasion by combining clinicopathologic factors in FIGO stage IB cervical cancer patients treated with radical hysterectomy
12 Total patients (n=360) Exclusion due to Conization (n=46) No SCC-Ag, Cyfra 21-1 (n=9) No MRI (n=5) Non-SCC, ASC, AC (n=2) Total enrolled patients (n=298) Figure 1. Inclusion criteria. SCC, squamous cell carcinoma; ASC, adenosquamous cell carcinoma; AC, adenocarcinoma; MRI, magnetic resonance imaging; SCC-Ag, squamous cell carcinoma-antigen; Cyfra 21-1, an enzyme immunoassay measuring serum fragments of cytokeratin 19.
13 Materials and methods Piver type III RH with retroperitoneal lymphadenectomy between February 2000 and March 2015 Retrospective review of clinicopathologic data of 298 patients with FIGO stage IB cervical cancer Nomogram Multivariate logistic regression analysis of preoperative clinicopathologic factors rms software package in R (
14 Results
15 Table 1. Comparison of preoperative clinicopathologic factors between patients with and without microscopic parametrial invasion Factors Microscopic parametrial invasion Negative (n = 234) Positive (n = 64) p-value Age (year) 46.0 ( ) 51.0 ( ) Parity 2 (0 5) 2 (0 6) BMI (kg/m 2 ) Surgical approach ARH 156 (77.6) 45 (22.4) LRH 70 (83.3) 14 (16.7) RRH 8 (61.5) 5 (38.5) Histology SCC 174 (78.7) 47 (21.3) AC 49 (83.1) 10 (16.9) ASC 11 (61.1) 7 (38.9) Grade (80.6) 18 (19.4) (78.3) 40 (21.7) 3 15 (71.4) 6 (28.6)
16 Table 1. Comparison of preoperative clinicopathologic factors between patients with and without microscopic parametrial invasion Factors Microscopic parametrial invasion Negative (n = 234) Positive (n = 64) p-value Menopasue No 161 (83.4) 32 (16.6) Yes 73 (69.5) 32 (30.5) FIGO stage <0.001 IB1 200 (90.1) 22 (9.9) IB2 34 (44.7) 42 (55.3) Disruption of cervical stromal ring on MRI No 209 (93.7) 14 (6.3) Yes 25 (33.3) 50 (66.7) <0.001 Tumor volume on MRI (cm 3 ) 7.9 ( ) 29.7 ( ) <0.001 Serum SCC-Ag (ng/ml) 0.9 ( ) 3.5 ( ) <0.001 Serum Cyfra 21-1 (ng/ml) 1.1 ( ) 2.3 ( ) <0.001
17 Table 2. Multivariate analysis of preoperative clinicopathologic factors for predicting parametrial invasion Variables Disruption of cervical stromal ring on MRI Multivariate analysis Odds ratio (95% CI) p-value ( ) <0.001 Menopause ( ) Serum SCC-Ag (ng/ml)* ( ) Tumor volume on MRI (cm 3 )* ( ) <0.001 *Continuous variables
18
19
20 Hosmer Lemeshow test, p = 0.314
21 Table 3. Predicted probability of parametrial invasion and actual parametrial invasion rate according to risk groups Low-risk group High-risk group Predefined predicted probability of PMI (%) <10 10 Total score (points) <38 38 Number of patients Predicted probability of PMI (%) Actual PMI rate (%) 2.5 (5 out of 200 patients) 60.2 (59 out of 98 patients)
22 Conclusions We developed a preoperative nomogram predicting PMI in surgically-treated FIGO stage IB cervical cancer patients In terms of the costs and utility of treatment, the use of postoperative chemoradiation should be minimized The probabilities from this nomogram may have the potential to provide valuable guidance for physicians regarding the primary management in FIGO stage IB cervical cancer patients
23 Thank you for your attention
Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria
Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department
More informationNeoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
Case Report Obstet Gynecol Sci 2014;57(6):539-543 http://dx.doi.org/10.5468/ogs.2014.57.6.539 pissn 2287-8572 eissn 2287-8580 Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for
More informationLearning curve analysis of laparoscopic radical hysterectomy for gynecologic oncologists without open counterpart experience
Original Article Obstet Gynecol Sci 2015;58(5):377-384 http://dx.doi.org/10.5468/ogs.2015.58.5.377 pissn 2287-8572 eissn 2287-8580 Learning curve analysis of laparoscopic radical hysterectomy for gynecologic
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial
Gynecologic Cancer InterGroup Cervix Cancer Research Network The SHAPE Trial Comparing radical hysterectomy and pelvic node dissection against simple hysterectomy and pelvic node dissection in patients
More informationA phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008
A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator
More informationFactors associated with parametrial involvement in patients with stage IB1 cervical cancer: who is suitable for less radical surgery?
Original Article Obstet Gynecol Sci 2018;61(1):88-94 https://doi.org/10.5468/ogs.2018.61.1.88 pissn 2287-8572 eissn 2287-8580 Factors associated with parametrial involvement in patients with stage IB1
More informationAn Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2016;48(1):259-265 Original Article http://dx.doi.org/10.4143/crt.2014.370 Open Access An Alternative Triage Strategy Based on Preoperative MRI for Avoiding
More informationPrognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis
NJOG 2009 June-July; 4 (1): 19-24 Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis Eliza Shrestha 1, Xiong Ying 1,2, Liang Li-Zhi 1,2, Zheng Min 1,2,
More informationManagement of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.
Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
More informationCorrelation of intermediate risk factors with prognostic factors in patients with early cervical cancer
대한부인종양콜포스코피학회제 24 차학술대회 Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer Seoul National University Bundang Hospital Eun Jung Soh, M.D. Cervical cancer
More informationPrognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases
Original Article J Gynecol Oncol Vol. 24, No. 3:229-235 pissn 2005-0380 eissn 2005-0399 Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic
More informationUPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER
UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationRole of Surgery in Cervical Cancer & Research Questions
Role of Surgery in Cervical Cancer & Research Questions Arb-aroon Lertkhachonsuk, M.D., Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Role of surgery in cervical cancer
More informationEvolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience
Original Article on Cervical Cancer Evolution of radical hysterectomy for cervical cancer along the last two decades: single institution experience Claudia Arispe, Ana Isabel Pomares, Javier De Santiago,
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University ijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26054
More informationAnalysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix
DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationIs Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:
More informationPrognostic significance of positive lymph node number in early cervical cancer
1052 Prognostic significance of positive lymph node number in early cervical cancer JUNG WOO PARK and JONG WOON BAE Department of Obstetrics and Gynecology, Dong A University Hospital, Dong A University
More informationONCOLOGY LETTERS 3: , 2012
ONCOLOGY LETTERS 3: 641-645, 2012 Treatment of early bulky cervical cancer with neoadjuvant paclitaxel, carboplatin and cisplatin prior to laparoscopical radical hysterectomy and pelvic lymphadenectomy
More informationCorrespondence should be addressed to Dae Sik Yang;
Hindawi BioMed Research International Volume 2017, Article ID 2917925, 9 pages https://doi.org/10.1155/2017/2917925 Clinical Study Validation of Nomograms for Survival and Metastases after Hysterectomy
More informationMRI in Cervix and Endometrial Cancer
28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial
More informationRESEARCH ARTICLE. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.11.6935 Prognostic Model in Patients with Early-stage Squamous Cell Carcinoma of the Uterine Cervix RESEARCH ARTICLE Prognostic Model in Patients with Early-stage
More informationRESEARCH ARTICLE. Abstract. Introduction
RESEARCH ARTICLE Lack of any Impact of Histopathology Type on Prognosis in Patients with Early-Stage Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix Fatma Teke 1 *, Adnan Yoney 2, Memik
More informationRESEARCH ARTICLE. Abstract. Introduction. Materials and Methods
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.14.5951 Pathologic Risk Factors and Outcomes of Early-Stage Cervical Carcinoma RESEARCH ARTICLE Pathologic Risk Factors and Oncologic Outcomes in Early-stage
More informationOriginal Article. Introduction. Tae-Kyu Jang, So-Jin Shin, Hyewon Chung, Sang-Hoon Kwon, Soon-Do Cha, Eunbi Lee, Changmin Shin, Chi-Heum Cho
Original Article Obstet Gynecol Sci 2017;60(6):549-557 https://doi.org/10.5468/ogs.2017.60.6.549 pissn 2287-8572 eissn 2287-8580 A retrospective comparison of outcome in IB2 and IIA cervical cancer patients
More informationInfluence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer
Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer Jason D. Wright, MD, Yongemei Huang, MD/PhD, William M. Burke, MD, et al. Journal Club March 16, 2016 Blaine Campbell-PGY2 Objective
More informationOutcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix
British Journal of Cancer (2010) 102, 1692 1698 All rights reserved 0007 0920/10 www.bjcancer.com Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix J-Y Park
More informationRitu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University
Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States
More informationUpdate on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer
Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Nicoletta Colombo, MD University of Milan-Bicocca European Institute of Oncology Milan, Italy NACT in Cervical Cancer NACT Stage -IB2 -IIA>4cm
More informationThe clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine
More informationFactors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage
Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage Jessica Johns, MD Jeffrey Killeen, MD Robert Kim, MD Hyeong Jun Ahn, PhD None Disclosures
More informationAdjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals
6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy
More informationIndependent risk factors for ovarian metastases in stage IA IIB cervical carcinoma
Received: 10 January 2018 Revised: 8 August 2018 Accepted: 13 August 2018 DOI: 10.1111/aogs.13442 ORIGINAL RESEARCH ARTICLE Independent risk factors for ovarian metastases in stage IA IIB cervical carcinoma
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationNomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
Original Article Obstet Gynecol Sci 2017;60(5):440-448 https://doi.org/10.5468/ogs.2017.60.5.440 pissn 2287-8572 eissn 2287-8580 Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing
More informationAn Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature
Archives of Clinical and Medical Case Reports doi: 10.26502/acmcr.9655003 Volume 1, Issue 1 Case Report An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review
More informationIntra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer
Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical
More informationCoversheet for Network Site Specific Group Agreed Documentation
Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance
More informationMANAGEMENT OF CERVICAL CANCER
MANAGEMENT OF CERVICAL CANCER Dr. Ujeen Shrestha Malla* and Prof. Dr. Zhang Shui Rong Department of Obstetrics and Gynaecology, Clinical Medical College of Yangtze University, Jingzhou Central Hospital,
More informationESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data
ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data David Cibula Gynecologic Oncology Centre General University Hospital
More informationCervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
More informationECC or Margins Positive?
CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,
More informationDae Woo Lee 1, Young Tae Kim 1, Jae Hoon Kim 1, Sunghoon Kim 1, Sang Wun Kim 1, Eun Ji Nam 1, Jae Wook Kim 2 INTRODUCTION
J Gynecol Oncol Vol. 21, No. 1:18-23, March 2010 DOI:10.3802/jgo.2010.21.1.18 Original Article Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer
More informationOriginal Article. Introduction. Soyi Lim 1, Seok-Ho Lee 2, Kwang Beom Lee 1, Chan-Yong Park 1
Original Article Obstet Gynecol Sci 2016;59(3):184-191 http://dx.doi.org/10.5468/ogs.2016.59.3.184 pissn 2287-8572 eissn 2287-8580 The influence of number of high risk factors on clinical outcomes in patients
More informationFounding Editorial Board Meeting of the JGO. Date & Time: November 14 th (Sat) 2015, 6:30~7:30AM Venue: Crystal Ballroom (2F) Lotte Hotel, Seoul
Founding Editorial Board Meeting of the JGO Date & Time: November 14 th (Sat) 2015, 6:30~7:30AM Venue: Crystal Ballroom (2F) Lotte Hotel, Seoul Objective of this meeting Share the current status of the
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationInvasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous
Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior
More informationPrognostic Impact of Histology in Patients with Cervical Squamous Cell Carcinoma, Adenocarcinoma and Small Cell Neuroendocrine Carcinoma
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.9.5355 Prognostic Impact of Histology in Patients with Cervical Cancer RESEARCH ARTICLE Prognostic Impact of Histology in Patients with Cervical Squamous Cell
More informationMultivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy
Original Article J Gynecol Oncol Vol. 24, No. 3:222-228 pissn 2005-0380 eissn 2005-0399 Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic
More informationSession Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic
Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications Andres A. Roma, MD Cleveland Clinic No Disclosures In the past 12 months, I have not had
More informationCPC on Cervical Pathology
CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade
More informationLocally advanced disease & challenges in management
Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix
THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April
More informationUterine Cervix. Protocol applies to all invasive carcinomas of the cervix.
Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying
More informationof surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles
chapter 14. Surgical management of early invasive cervical cancer CHAPTER 1 Wertheim described the principles of surgical management of invasive cervical cancer more than 100 years ago in his treatise
More informationStage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante
Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical
More informationYing Chen 1,3, Lei Zhang 1,3, Jing Tian 1, Xiubao Ren 2 and Quan Hao 1*
Chen et al. Cancer Cell International 2013, 13:6 PRIMARY RESEARCH Open Access Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative
More informationAlgorithms for management of Cervical cancer
Algithms f management of Cervical cancer Algithms f management of cervical cancer are based on existing protocols and guidelines within the ESGO comunity and prepared by ESGO Educational Committe as a
More informationThe role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer
Acta Obstet Gynecol Scand 2000; 79: 140 144 Copyright C Acta Obstet Gynecol Scand 2000 Printed in Denmark All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE
More informationThe new FIGO classification in endometrial carcinoma
The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO
More informationCervical Cancer Guidelines L and SC Network July Introduction:
Cervical Cancer Guidelines L and SC Network July 2018 Introduction: There was a total number of 442 cases of cervix cancer diagnosed in Lancashire and South Cumbria Cancer Network in the period 2005 2009
More informationNecessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion
J Korean Med Sci 2010; 25: 552-6 ISSN 1011-8934 DOI: 10.3346/jkms.2010.25.4.552 Necessity of Radical Hysterectomy for Endometrial Cancer atients with Cervical Invasion To determine whether radical hysterectomy
More informationRole and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh
Role and Techniques of Surgery in Carcinoma Cervix Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Points for Discussion Pattern of spread Therapeutic options Types of surgical procedures
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationPossibility of less radical treatment for patients with early invasive uterine cervical cancer
doi:10.1111/jog.12980 J. Obstet. Gynaecol. Res. Vol. 42, No. 7: 876 882, July 2016 Possibility of less radical treatment for patients with early invasive uterine cervical cancer Miseon Kim, Shinichi Ishioka,
More informationWhat We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital
Thai Journal of Obstetrics and Gynaecology April 2008, Vol. 16, pp. 79-8561-167 SPECIAL ARTICLE What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital Jatupol
More informationLack of Effect of Perioperative Blood Transfusion during Radical Hysterectomy with Lymph Node Dissection on the Prognosis of Cervical Cancer Stage Ib
RESEARCH COMMUNICATION Lack of Effect of Perioperative Blood Transfusion during Radical Hysterectomy with Lymph Node Dissection on the Prognosis of Cervical Cancer Stage Ib Jitti Hanprasertpong 1 *, Saibua
More informationOutcomes and prognostic factors of cervical cancer after concurrent chemoradiationjog_
bs_bs_banner doi:10.1111/j.1447-0756.2012.01871.x J. Obstet. Gynaecol. Res. Vol. 38, No. 11: 1315 1320, November 2012 Outcomes and prognostic factors of cervical cancer after concurrent chemoradiationjog_1871
More informationORIGINAL PAPER. Department of Radiology, Nagoya University Graduate School of Medicine, Aichi, Japan 2
Nagoya J. Med. Sci. 79. 211 ~ 220, 2017 doi:10.18999/nagjms.79.2.211 ORIGINAL PAPER Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine
More informationMR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI
MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI Poster No.: C-1191 Congress: ECR 2010 Type: Educational Exhibit Topic: Genitourinary Authors: M. Takeuchi, K. Matsuzaki,
More informationIndication for Surgery in Endometrial & Cervical Cancer. everything you need to know in 30 minutes!!! Fabio Landoni, MD Gynecologic Department
Indication for Surgery in Endometrial & Cervical Cancer everything you need to know in 30 minutes!!! Fabio Landoni, MD Gynecologic Department Risk Factors LVSI Myometrial invasion Nodes grade Adjuvant
More informationT an almost uniform level in every International
Stage Ib, /la, and llb Cervix Cancer, Postsurgical Staging, and Prognosis TOSHITAKA MATSUYAMA, MD, ISAO INOUE, MD, NAOKI TSUKAMOTO, MD, MASAMlCHl KASHIMURA, MD, TOSHIHARU KAMURA, MD, TOSHlAKl SAITO, MD,
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationPrognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy
Prognostic Impact of Hyperglycemia in Patients with Locally Advanced Squamous Cell Carcinoma of Cervix Receiving Definite Radiotherapy 2016.04.08 KCCH 김문홍 DM and prediabetes in cancer Negative impact on
More informationDisclosure. No Conflicts of Interest
Phase III Randomized Trial of Laparoscopic or Robotic Radical Hysterectomy vs. Abdominal Radical Hysterectomy in Patients with Early-Stage Cervical Cancer: LACC Trial Pedro T. Ramirez, Michael Frumovitz,
More informationComparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I II cervical cancer
518 Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I II cervical cancer MAKOTO YAMAUCHI, TAKESHI FUKUDA, TAKUMA WADA, MASARU KAWANISHI,
More informationPredictors and Patterns of recurrence after radical surgery in ampulla of vater cancer: Comparison analysis between early and late recu rrence.
Predictors and Patterns of recurrence after radical surgery in ampulla of vater cancer: Comparison analysis between early and late recu rrence. Division of Hepatobiliary & Pancreatic Surgery Department
More informationChapter 5 Stage III and IVa disease
Page 55 Chapter 5 Stage III and IVa disease Overview Concurrent chemoradiotherapy (CCRT) is recommended for stage III and IVa disease. Recommended regimen for the chemotherapy portion generally include
More informationSignificance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma
ORIGINAL STUDY Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma Jeong-Yeol Park, MD, PhD, Dae-Yeon Kim, MD, PhD, Dae-Shik Suh, MD, PhD, Jong-Hyeok Kim, MD, PhD, Yong-Man
More informationComparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer
Original Article J Gynecol Oncol Vol. 23, No. 4:235-241 pissn 2005-0380 eissn 2005-0399 Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin
More informationChemotherapy for Cervical Cancer. Matsue City Hospital Junzo Kigawa
Chemotherapy for Cervical Cancer Matsue City Hospital Junzo Kigawa Introduction Worldwide, cervical cancer is the second most common cancer in women and affects 530,000 new patients and 275,000 deaths.
More informationRetrospective evaluation of clinical and pathological features, as well as diagnostic and treatment protocols of primary vaginal malignancy
ORIGINAL PAPER / GYNECOLOGY Ginekologia Polska 2016, vol. 87, no. 8, 541 545 Copyright 2016 Via Medica ISSN 0017 0011 DOI: 10.5603/GP.2016.0041 Retrospective evaluation of clinical and pathological features,
More informationCompleting or Abandoning Radical Hysterectomy in Early-Stage Lymph NodeYPositive Cervical Cancer
ORIGINAL STUDY Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph NodeYPositive Cervical Cancer Impact on Disease-Free Survival and Treatment-Related Toxicity Marloes Derks, MD,* Freek
More informationSurgical and obstetrical outcomes after laparoscopic radical trachelectomy and pelvic lymphadenectomy for early cervical cancer
Original Article Obstet Gynecol Sci 2016;59(5):373-378 http://dx.doi.org/10.5468/ogs.2016.59.5.373 pissn 2287-8572 eissn 2287-8580 Surgical and obstetrical outcomes after laparoscopic radical trachelectomy
More informationFertility-sparing surgery in young patients with cervical cancer
Fertility-sparing surgery in young patients with cervical cancer Pr Catherine Uzan Chef de service Chirurgie et cancérologie gynécologique et mammaire, Pitié Evaluation BEFORE surgery Cancer: stage, type
More informationThe relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer
Original Article J Gynecol Oncol Vol. 25,. 2:9-96 http://dx.doi.org/.382/jgo.24.25.2.9 pissn 25-38 eissn 25-399 The relationship between positive peritoneal cytology and the prognosis of patients with
More informationJMSCR Vol 05 Issue 06 Page June 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and
More informationRisk assessment of lymph node metastasis before surgery in endometrial cancer: Do we need a clinical trial for low-risk patients?
bs_bs_banner doi:10.1111/jog.12281 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 322 326, February 2014 Risk assessment of lymph node metastasis before surgery in endometrial cancer: Do we need a clinical
More informationKe Hu, Weiping Wang, Xiaoliang Liu, Qingyu Meng and Fuquan Zhang *
Hu et al. Radiation Oncology (2018) 13:249 https://doi.org/10.1186/s13014-018-1197-5 RESEARCH Open Access Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after
More informationPrimary tumor SUV max on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy
216 Primary tumor SUV max on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy SHIGETAKA YAGI 1, TAMAKI YAHATA 1, YASUSHI MABUCHI
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationEffectiveness of cervical cancer therapy using neoadjuvant chemotherapy in combination with radical surgery: a metaanalysis
Original Article Effectiveness of cervical cancer therapy using neoadjuvant chemotherapy in combination with radical surgery: a metaanalysis Yijie Fu 1, Tianmin Zhu 2, Hui Li 3 1 Department of Internal
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More information